You are here

zavegepant

Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK

Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK

Endpoints

Flag link:

Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval

Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval

BioSpace

Flag link:

Pfizer cites positive results on nasal spray migraine treatment

Pfizer cites positive results on nasal spray migraine treatment

Medical Xpress

Flag link:

Pfizer and Biohaven close collaboration agreements

Pfizer and Biohaven close collaboration agreements

Pharmaceutical Business Review

Flag link:

Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role

Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role

Fierce Biotech

Flag link:

Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs

Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs

Yahoo/Reuters

Flag link: